… and identified as a novel coronavirus. Due to its contagious nature, the virus spreads rapidly
and causes coronavirus disease 2019 (COVID-19). The global tally of COVID-19 was 28 …

… against COVID-19 and some promising results have been achieved. This review focuses on
several therapeutic options for COVID-19, such as anti-viral drugs, vaccines, plasma therapy…

… treatment of the emerging COVID-19. Finally, we summarize clinical trials of some potential
therapeutic drugs and the … This review provides some insights for the treatment of COVID-19. …

… therapeutic option for the management of COVID-19. In early February, Wang et al [3]
demonstrated potent in vitro activity of chloroquine against SARS-CoV-2 with an EC 50 at 48 hours …

… One of the greatest challenges for clinicians in the treatment of COVID-19 has … COVID-19
therapeutic options as of October 2021 in the context of a clinical approach based on disease …

… of macrophage-coronavirus interactions. We also discussed therapeutic approaches to target
… under evaluation in clinical trials for coronavirus disease 2019 patients. Additionally, we …

… an option for the therapy of patients with COVID-19[10]. In a case report, remdisivir reatment
was started intravenous on day 7 in a patient with COVID-… COVID-19 respiratory disease [12] …

… against the disease, but most … therapeutic options for COVID-19, including antivirals,
anti-inflammatories, convalescent plasma therapy, monoclonal antibodies, immunoglobulin therapy, …

… , severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease
(COVID-19), … Currently, several therapeutic options for COVID-19 are proposed and vaccine …

… coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus disease 2019
(COVID-… identify a viable therapeutic option to mitigate the damage the disease causes. In …